Skip to content
zameds

Tadalafil (Ciatad)

Tadalafil

Ranbaxy Pharmaceutical (Pty) Ltd

Every registration of this product has been cancelled.

S4

Registration

Applicant
Ranbaxy Pharmaceutical (Pty) Ltd
Certificate holder
Ranbaxy Pharmaceuticals (Pty) Ltd
Registrations
2
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Ciatad 5

Each tablet contains TADALAFIL 5,0 mg

5Film coated tablets.50001050/7.1.5/0010Approved 12 July 2022CancelledS4PIPIL
Ciatad 20

Each tablet contains TADALAFIL 20,0 mg

20Film coated tablets.50001150/7.1.5/0011Approved 12 July 2022CancelledS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Tadalafil

  • S4: Tadalafil

    Consolidated Schedules 06 July 2026, line 8086

Pharmacological class: Vasodilators - peripheral. (class 7.1.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C22H19N3O4389.40 g/mol

(2R,8R)-2-(1,3-Benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione

Drag to rotate. Structure from PubChem CID 110635.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles